Changping Wu

5.2k total citations · 2 hit papers
78 papers, 3.3k citations indexed

About

Changping Wu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Changping Wu has authored 78 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 25 papers in Molecular Biology and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Changping Wu's work include Cancer Immunotherapy and Biomarkers (19 papers), Immune Cell Function and Interaction (10 papers) and Immunotherapy and Immune Responses (8 papers). Changping Wu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (19 papers), Immune Cell Function and Interaction (10 papers) and Immunotherapy and Immune Responses (8 papers). Changping Wu collaborates with scholars based in China, United States and Sweden. Changping Wu's co-authors include Jingting Jiang, Xiao Zheng, Xueguang Zhang, Yibei Zhu, Binfeng Lu, Lujun Chen, Ning Xu, Bin Xu, Jiemin Zhao and Qi Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Changping Wu

77 papers receiving 3.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling

2019 425 citations Xiao Zheng, Lujun Chen et al. profile →
N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA

2022 123 citations Xiao Zheng, Qi Wang et al. Cancer Communications profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Changping Wu	1.6k	1.2k	1.0k	820	598	78	3.3k
Oronzo Brunetti	1.5k 1.0×	1.1k 0.9×	692 0.7×	783 1.0×	525 0.9×	126	3.1k
Karim A. Benhadji	2.1k 1.4×	1.8k 1.5×	669 0.6×	540 0.7×	539 0.9×	117	3.8k
Jun Guo	2.3k 1.4×	1.7k 1.4×	820 0.8×	519 0.6×	642 1.1×	208	3.5k
Karin Leandersson	1.5k 1.0×	1.5k 1.3×	1.7k 1.7×	541 0.7×	377 0.6×	69	3.5k
Ricardo R. Lastra	1.1k 0.7×	1.2k 1.0×	663 0.6×	781 1.0×	391 0.7×	76	3.1k
Björn Nodin	1.5k 0.9×	1.0k 0.9×	612 0.6×	594 0.7×	579 1.0×	118	2.8k
Ryusei Matsuyama	1.8k 1.2×	1.1k 0.9×	592 0.6×	869 1.1×	1.2k 1.9×	168	3.8k
Zhanlong Shen	1.1k 0.7×	1.2k 1.0×	742 0.7×	716 0.9×	488 0.8×	93	2.7k
Jakob Dupont	1.7k 1.1×	2.5k 2.1×	686 0.7×	505 0.6×	582 1.0×	111	5.1k
Su Yin Lim	1.6k 1.0×	1.3k 1.0×	1.4k 1.3×	474 0.6×	415 0.7×	50	3.1k

Countries citing papers authored by Changping Wu

Since Specialization

Citations

This map shows the geographic impact of Changping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changping Wu more than expected).

Fields of papers citing papers by Changping Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changping Wu. The network helps show where Changping Wu may publish in the future.

Co-authorship network of co-authors of Changping Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Changping Wu. A scholar is included among the top collaborators of Changping Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changping Wu. Changping Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yang, et al.. (2025). Three-dimensional (3D)-printed custom-made titanium ribs for chest wall reconstruction post-desmoid fibromatosis resection. PubMed. 30(1). 2456303–2456303. 1 indexed citations

Chen, Lujun, Hao Huang, Ziyi Huang, et al.. (2023). Prognostic values of tissue-resident CD8+T cells in human hepatocellular carcinoma and intrahepatic cholangiocarcinoma. World Journal of Surgical Oncology. 21(1). 124–124. 23 indexed citations

Zheng, Xiao, Qi Wang, You Zhou, et al.. (2022). N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Communications. 42(12). 1347–1366. 123 indexed citations breakdown →

Chen, Yaping, Hao Huang, Yuan Li, et al.. (2022). TIGIT Blockade Exerts Synergistic Effects on Microwave Ablation Against Cancer. Frontiers in Immunology. 13. 832230–832230. 28 indexed citations

Song, Xing, Yingjie Shao, Yun Ding, et al.. (2018). Radiotherapy Upregulates Programmed Death Ligand-1 through the Pathways Downstream of Epidermal Growth Factor Receptor in Glioma. EBioMedicine. 28. 105–113. 30 indexed citations

Geng, Yiting, Danxia Zhu, Chen Wu, et al.. (2018). A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. International Immunopharmacology. 65. 503–510. 127 indexed citations

Li, Jing, Lujun Chen, Xiao Zheng, et al.. (2017). Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy. Cellular Physiology and Biochemistry. 41(3). 907–920. 81 indexed citations

Zhu, Danxia, Cheng Fang, Mei Ji, et al.. (2015). Prognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysis.. PubMed. 8(9). 15340–50. 5 indexed citations

Shi, Liangrong, Xiaodong Li, Honglei Pei, et al.. (2015). Phase II study of computed tomography-guided 125I-seed implantation plus chemotherapy for locally recurrent rectal cancer. Radiotherapy and Oncology. 118(2). 375–381. 7 indexed citations

10.

Shi, Lehua, Qian Wu, Jiemin Zhao, et al.. (2015). Hepatic arterial infusion plus systemic chemotherapy as third-line or later treatment in colorectal liver metastases. Clinical & Translational Oncology. 17(11). 870–875. 2 indexed citations

11.

Zhou, Fuxiang, et al.. (2014). Suppression of telomere-binding protein TPP1 resulted in telomere dysfunction and enhanced radiation sensitivity in telomerase-negative osteosarcoma cell line. Biochemical and Biophysical Research Communications. 445(2). 363–368. 23 indexed citations

12.

Dang, Shipeng, Huanbai Xu, Chuanshan Xu, et al.. (2014). Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis. Autophagy. 10(7). 1301–1315. 98 indexed citations

13.

Geng, Yiting, Hui Wang, Qing Li, et al.. (2014). Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance. International Journal of Clinical Oncology. 20(2). 273–281. 109 indexed citations

14.

He, Wenting, Dachuan Zhang, Jingting Jiang, Ping Liu, & Changping Wu. (2014). The relationships between the chemosensitivity of human gastric cancer to paclitaxel and the expressions of class III β-tubulin, MAPT, and survivin. Medical Oncology. 31(5). 950–950. 27 indexed citations

15.

Wu, Chen, Jing Qian, Shaohua He, et al.. (2013). WT1 Promotes Invasion of NSCLC via Suppression of CDH1. Journal of Thoracic Oncology. 8(9). 1163–1169. 30 indexed citations

16.

Jiang, Jingting, Changping Wu, & Binfeng Lu. (2013). Cytokine-induced killer cells promote antitumor immunity. Journal of Translational Medicine. 11(1). 83–83. 119 indexed citations

17.

Jiang, Jingting, Xiao Zheng, Xiao Xu, et al.. (2011). Prognostic Significance of miR-181b and miR-21 in Gastric Cancer Patients Treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin. PLoS ONE. 6(8). e23271–e23271. 69 indexed citations

18.

Shen, Hua, et al.. (2010). The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: A phase II study. International Journal of Hyperthermia. 27(1). 27–32. 28 indexed citations

19.

Jiang, Jingting, Changping Wu, Guanghua Luo, et al.. (2009). Expression of apolipoprotein M in human hepatocellular carcinoma tissues. Acta Histochemica. 113(1). 53–57. 19 indexed citations

20.

Jiang, Jingting, Ning Xu, Xiaoying Zhang, & Changping Wu. (2007). Lipids changes in liver cancer. Journal of Zhejiang University SCIENCE B. 8(6). 398–409. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact